Cargando…
Immune consequences of penfluridol treatment associated with inhibition of glioblastoma tumor growth
Glioblastoma is the most common and lethal brain tumor associated with only 12% median survival rate of patients. Despite the development of advanced surgical, radiation or use of combinations of anti-cancer drugs, treatment for glioblastoma patients is still a challenge. The major contributing fact...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564593/ https://www.ncbi.nlm.nih.gov/pubmed/28512255 http://dx.doi.org/10.18632/oncotarget.17425 |